Serveur d'exploration MERS

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Glycoprotein hormone receptors: link between receptor homodimerization and negative cooperativity.

Identifieur interne : 002337 ( PubMed/Corpus ); précédent : 002336; suivant : 002338

Glycoprotein hormone receptors: link between receptor homodimerization and negative cooperativity.

Auteurs : Eneko Urizar ; Lucia Montanelli ; Tiffany Loy ; Marco Bonomi ; Stéphane Swillens ; Céline Gales ; Michel Bouvier ; Guillaume Smits ; Gilbert Vassart ; Sabine Costagliola

Source :

RBID : pubmed:15889138

English descriptors

Abstract

The monomeric model of rhodopsin-like G protein-coupled receptors (GPCRs) has progressively yielded the floor to the concept of GPCRs being oligo(di)mers, but the functional correlates of dimerization remain unclear. In this report, dimers of glycoprotein hormone receptors were demonstrated in living cells, with a combination of biophysical (bioluminescence resonance energy transfer and homogenous time resolved fluorescence/fluorescence resonance energy transfer), functional and biochemical approaches. Thyrotropin (TSHr) and lutropin (LH/CGr) receptors form homo- and heterodimers, via interactions involving primarily their heptahelical domains. The large hormone-binding ectodomains were dispensable for dimerization but modulated protomer interaction. Dimerization was not affected by agonist binding. Observed functional complementation indicates that TSHr dimers may function as a single functional unit. Finally, heterologous binding-competition studies, performed with heterodimers between TSHr and LH/CG-TSHr chimeras, demonstrated the unsuspected existence of strong negative cooperativity of hormone binding. Tracer desorption experiments indicated an allosteric behavior in TSHr and, to a lesser extent, in LH/CGr and FSHr homodimers. This study is the first report of homodimerization associated with negative cooperativity in rhodopsin-like GPCRs. As such, it may warrant revisitation of allosterism in the whole GPCR family.

DOI: 10.1038/sj.emboj.7600686
PubMed: 15889138

Links to Exploration step

pubmed:15889138

Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Glycoprotein hormone receptors: link between receptor homodimerization and negative cooperativity.</title>
<author>
<name sortKey="Urizar, Eneko" sort="Urizar, Eneko" uniqKey="Urizar E" first="Eneko" last="Urizar">Eneko Urizar</name>
<affiliation>
<nlm:affiliation>IRIBHM, Université Libre de Bruxelles, Campus Erasme, Brussels, Belgium.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Montanelli, Lucia" sort="Montanelli, Lucia" uniqKey="Montanelli L" first="Lucia" last="Montanelli">Lucia Montanelli</name>
</author>
<author>
<name sortKey="Loy, Tiffany" sort="Loy, Tiffany" uniqKey="Loy T" first="Tiffany" last="Loy">Tiffany Loy</name>
</author>
<author>
<name sortKey="Bonomi, Marco" sort="Bonomi, Marco" uniqKey="Bonomi M" first="Marco" last="Bonomi">Marco Bonomi</name>
</author>
<author>
<name sortKey="Swillens, Stephane" sort="Swillens, Stephane" uniqKey="Swillens S" first="Stéphane" last="Swillens">Stéphane Swillens</name>
</author>
<author>
<name sortKey="Gales, Celine" sort="Gales, Celine" uniqKey="Gales C" first="Céline" last="Gales">Céline Gales</name>
</author>
<author>
<name sortKey="Bouvier, Michel" sort="Bouvier, Michel" uniqKey="Bouvier M" first="Michel" last="Bouvier">Michel Bouvier</name>
</author>
<author>
<name sortKey="Smits, Guillaume" sort="Smits, Guillaume" uniqKey="Smits G" first="Guillaume" last="Smits">Guillaume Smits</name>
</author>
<author>
<name sortKey="Vassart, Gilbert" sort="Vassart, Gilbert" uniqKey="Vassart G" first="Gilbert" last="Vassart">Gilbert Vassart</name>
</author>
<author>
<name sortKey="Costagliola, Sabine" sort="Costagliola, Sabine" uniqKey="Costagliola S" first="Sabine" last="Costagliola">Sabine Costagliola</name>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">PubMed</idno>
<date when="2005">2005</date>
<idno type="RBID">pubmed:15889138</idno>
<idno type="pmid">15889138</idno>
<idno type="doi">10.1038/sj.emboj.7600686</idno>
<idno type="wicri:Area/PubMed/Corpus">002337</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">002337</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en">Glycoprotein hormone receptors: link between receptor homodimerization and negative cooperativity.</title>
<author>
<name sortKey="Urizar, Eneko" sort="Urizar, Eneko" uniqKey="Urizar E" first="Eneko" last="Urizar">Eneko Urizar</name>
<affiliation>
<nlm:affiliation>IRIBHM, Université Libre de Bruxelles, Campus Erasme, Brussels, Belgium.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Montanelli, Lucia" sort="Montanelli, Lucia" uniqKey="Montanelli L" first="Lucia" last="Montanelli">Lucia Montanelli</name>
</author>
<author>
<name sortKey="Loy, Tiffany" sort="Loy, Tiffany" uniqKey="Loy T" first="Tiffany" last="Loy">Tiffany Loy</name>
</author>
<author>
<name sortKey="Bonomi, Marco" sort="Bonomi, Marco" uniqKey="Bonomi M" first="Marco" last="Bonomi">Marco Bonomi</name>
</author>
<author>
<name sortKey="Swillens, Stephane" sort="Swillens, Stephane" uniqKey="Swillens S" first="Stéphane" last="Swillens">Stéphane Swillens</name>
</author>
<author>
<name sortKey="Gales, Celine" sort="Gales, Celine" uniqKey="Gales C" first="Céline" last="Gales">Céline Gales</name>
</author>
<author>
<name sortKey="Bouvier, Michel" sort="Bouvier, Michel" uniqKey="Bouvier M" first="Michel" last="Bouvier">Michel Bouvier</name>
</author>
<author>
<name sortKey="Smits, Guillaume" sort="Smits, Guillaume" uniqKey="Smits G" first="Guillaume" last="Smits">Guillaume Smits</name>
</author>
<author>
<name sortKey="Vassart, Gilbert" sort="Vassart, Gilbert" uniqKey="Vassart G" first="Gilbert" last="Vassart">Gilbert Vassart</name>
</author>
<author>
<name sortKey="Costagliola, Sabine" sort="Costagliola, Sabine" uniqKey="Costagliola S" first="Sabine" last="Costagliola">Sabine Costagliola</name>
</author>
</analytic>
<series>
<title level="j">The EMBO journal</title>
<idno type="ISSN">0261-4189</idno>
<imprint>
<date when="2005" type="published">2005</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Allosteric Regulation</term>
<term>Animals</term>
<term>Bacterial Proteins (analysis)</term>
<term>Binding Sites</term>
<term>Cell Line</term>
<term>Cell Membrane (metabolism)</term>
<term>Cyclic AMP (biosynthesis)</term>
<term>Dimerization</term>
<term>Fluorescence Resonance Energy Transfer</term>
<term>Horses</term>
<term>Humans</term>
<term>Kidney</term>
<term>Luminescent Proteins (analysis)</term>
<term>Models, Molecular</term>
<term>Protein Binding</term>
<term>Protein Interaction Mapping</term>
<term>Protein Multimerization</term>
<term>Protein Structure, Tertiary</term>
<term>Receptors, FSH (chemistry)</term>
<term>Receptors, FSH (metabolism)</term>
<term>Receptors, LH (chemistry)</term>
<term>Receptors, LH (metabolism)</term>
<term>Receptors, Thyrotropin (chemistry)</term>
<term>Receptors, Thyrotropin (metabolism)</term>
<term>Recombinant Fusion Proteins (chemistry)</term>
<term>Recombinant Fusion Proteins (metabolism)</term>
<term>Sus scrofa</term>
<term>Thyroid Gland (metabolism)</term>
<term>Transfection</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="analysis" xml:lang="en">
<term>Bacterial Proteins</term>
<term>Luminescent Proteins</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="biosynthesis" xml:lang="en">
<term>Cyclic AMP</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="chemistry" xml:lang="en">
<term>Receptors, FSH</term>
<term>Receptors, LH</term>
<term>Receptors, Thyrotropin</term>
<term>Recombinant Fusion Proteins</term>
</keywords>
<keywords scheme="MESH" qualifier="metabolism" xml:lang="en">
<term>Cell Membrane</term>
<term>Receptors, FSH</term>
<term>Receptors, LH</term>
<term>Receptors, Thyrotropin</term>
<term>Recombinant Fusion Proteins</term>
<term>Thyroid Gland</term>
</keywords>
<keywords scheme="MESH" xml:lang="en">
<term>Allosteric Regulation</term>
<term>Animals</term>
<term>Binding Sites</term>
<term>Cell Line</term>
<term>Dimerization</term>
<term>Fluorescence Resonance Energy Transfer</term>
<term>Horses</term>
<term>Humans</term>
<term>Kidney</term>
<term>Models, Molecular</term>
<term>Protein Binding</term>
<term>Protein Interaction Mapping</term>
<term>Protein Multimerization</term>
<term>Protein Structure, Tertiary</term>
<term>Sus scrofa</term>
<term>Transfection</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">The monomeric model of rhodopsin-like G protein-coupled receptors (GPCRs) has progressively yielded the floor to the concept of GPCRs being oligo(di)mers, but the functional correlates of dimerization remain unclear. In this report, dimers of glycoprotein hormone receptors were demonstrated in living cells, with a combination of biophysical (bioluminescence resonance energy transfer and homogenous time resolved fluorescence/fluorescence resonance energy transfer), functional and biochemical approaches. Thyrotropin (TSHr) and lutropin (LH/CGr) receptors form homo- and heterodimers, via interactions involving primarily their heptahelical domains. The large hormone-binding ectodomains were dispensable for dimerization but modulated protomer interaction. Dimerization was not affected by agonist binding. Observed functional complementation indicates that TSHr dimers may function as a single functional unit. Finally, heterologous binding-competition studies, performed with heterodimers between TSHr and LH/CG-TSHr chimeras, demonstrated the unsuspected existence of strong negative cooperativity of hormone binding. Tracer desorption experiments indicated an allosteric behavior in TSHr and, to a lesser extent, in LH/CGr and FSHr homodimers. This study is the first report of homodimerization associated with negative cooperativity in rhodopsin-like GPCRs. As such, it may warrant revisitation of allosterism in the whole GPCR family.</div>
</front>
</TEI>
<pubmed>
<MedlineCitation Status="MEDLINE" Owner="NLM">
<PMID Version="1">15889138</PMID>
<DateCompleted>
<Year>2005</Year>
<Month>08</Month>
<Day>02</Day>
</DateCompleted>
<DateRevised>
<Year>2018</Year>
<Month>11</Month>
<Day>13</Day>
</DateRevised>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Print">0261-4189</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>24</Volume>
<Issue>11</Issue>
<PubDate>
<Year>2005</Year>
<Month>Jun</Month>
<Day>01</Day>
</PubDate>
</JournalIssue>
<Title>The EMBO journal</Title>
<ISOAbbreviation>EMBO J.</ISOAbbreviation>
</Journal>
<ArticleTitle>Glycoprotein hormone receptors: link between receptor homodimerization and negative cooperativity.</ArticleTitle>
<Pagination>
<MedlinePgn>1954-64</MedlinePgn>
</Pagination>
<Abstract>
<AbstractText>The monomeric model of rhodopsin-like G protein-coupled receptors (GPCRs) has progressively yielded the floor to the concept of GPCRs being oligo(di)mers, but the functional correlates of dimerization remain unclear. In this report, dimers of glycoprotein hormone receptors were demonstrated in living cells, with a combination of biophysical (bioluminescence resonance energy transfer and homogenous time resolved fluorescence/fluorescence resonance energy transfer), functional and biochemical approaches. Thyrotropin (TSHr) and lutropin (LH/CGr) receptors form homo- and heterodimers, via interactions involving primarily their heptahelical domains. The large hormone-binding ectodomains were dispensable for dimerization but modulated protomer interaction. Dimerization was not affected by agonist binding. Observed functional complementation indicates that TSHr dimers may function as a single functional unit. Finally, heterologous binding-competition studies, performed with heterodimers between TSHr and LH/CG-TSHr chimeras, demonstrated the unsuspected existence of strong negative cooperativity of hormone binding. Tracer desorption experiments indicated an allosteric behavior in TSHr and, to a lesser extent, in LH/CGr and FSHr homodimers. This study is the first report of homodimerization associated with negative cooperativity in rhodopsin-like GPCRs. As such, it may warrant revisitation of allosterism in the whole GPCR family.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Urizar</LastName>
<ForeName>Eneko</ForeName>
<Initials>E</Initials>
<AffiliationInfo>
<Affiliation>IRIBHM, Université Libre de Bruxelles, Campus Erasme, Brussels, Belgium.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Montanelli</LastName>
<ForeName>Lucia</ForeName>
<Initials>L</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Loy</LastName>
<ForeName>Tiffany</ForeName>
<Initials>T</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Bonomi</LastName>
<ForeName>Marco</ForeName>
<Initials>M</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Swillens</LastName>
<ForeName>Stéphane</ForeName>
<Initials>S</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Gales</LastName>
<ForeName>Céline</ForeName>
<Initials>C</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Bouvier</LastName>
<ForeName>Michel</ForeName>
<Initials>M</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Smits</LastName>
<ForeName>Guillaume</ForeName>
<Initials>G</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Vassart</LastName>
<ForeName>Gilbert</ForeName>
<Initials>G</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Costagliola</LastName>
<ForeName>Sabine</ForeName>
<Initials>S</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D003160">Comparative Study</PublicationType>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2005</Year>
<Month>05</Month>
<Day>12</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>England</Country>
<MedlineTA>EMBO J</MedlineTA>
<NlmUniqueID>8208664</NlmUniqueID>
<ISSNLinking>0261-4189</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D001426">Bacterial Proteins</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D008164">Luminescent Proteins</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D011962">Receptors, FSH</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D011974">Receptors, LH</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D011989">Receptors, Thyrotropin</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D011993">Recombinant Fusion Proteins</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="C054562">yellow fluorescent protein, Bacteria</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>E0399OZS9N</RegistryNumber>
<NameOfSubstance UI="D000242">Cyclic AMP</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName UI="D000494" MajorTopicYN="N">Allosteric Regulation</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D001426" MajorTopicYN="N">Bacterial Proteins</DescriptorName>
<QualifierName UI="Q000032" MajorTopicYN="N">analysis</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D001665" MajorTopicYN="N">Binding Sites</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D002460" MajorTopicYN="N">Cell Line</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D002462" MajorTopicYN="N">Cell Membrane</DescriptorName>
<QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D000242" MajorTopicYN="N">Cyclic AMP</DescriptorName>
<QualifierName UI="Q000096" MajorTopicYN="N">biosynthesis</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D019281" MajorTopicYN="N">Dimerization</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D031541" MajorTopicYN="N">Fluorescence Resonance Energy Transfer</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D006736" MajorTopicYN="N">Horses</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D007668" MajorTopicYN="N">Kidney</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D008164" MajorTopicYN="N">Luminescent Proteins</DescriptorName>
<QualifierName UI="Q000032" MajorTopicYN="N">analysis</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D008958" MajorTopicYN="N">Models, Molecular</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D011485" MajorTopicYN="N">Protein Binding</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D025941" MajorTopicYN="N">Protein Interaction Mapping</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D055503" MajorTopicYN="N">Protein Multimerization</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D017434" MajorTopicYN="N">Protein Structure, Tertiary</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D011962" MajorTopicYN="N">Receptors, FSH</DescriptorName>
<QualifierName UI="Q000737" MajorTopicYN="Y">chemistry</QualifierName>
<QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D011974" MajorTopicYN="N">Receptors, LH</DescriptorName>
<QualifierName UI="Q000737" MajorTopicYN="Y">chemistry</QualifierName>
<QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D011989" MajorTopicYN="N">Receptors, Thyrotropin</DescriptorName>
<QualifierName UI="Q000737" MajorTopicYN="Y">chemistry</QualifierName>
<QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D011993" MajorTopicYN="N">Recombinant Fusion Proteins</DescriptorName>
<QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName>
<QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D034421" MajorTopicYN="N">Sus scrofa</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D013961" MajorTopicYN="N">Thyroid Gland</DescriptorName>
<QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D014162" MajorTopicYN="N">Transfection</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<PubmedData>
<History>
<PubMedPubDate PubStatus="received">
<Year>2005</Year>
<Month>02</Month>
<Day>03</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="accepted">
<Year>2005</Year>
<Month>04</Month>
<Day>27</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed">
<Year>2005</Year>
<Month>5</Month>
<Day>13</Day>
<Hour>9</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline">
<Year>2005</Year>
<Month>8</Month>
<Day>3</Day>
<Hour>9</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez">
<Year>2005</Year>
<Month>5</Month>
<Day>13</Day>
<Hour>9</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList>
<ArticleId IdType="pubmed">15889138</ArticleId>
<ArticleId IdType="pii">7600686</ArticleId>
<ArticleId IdType="doi">10.1038/sj.emboj.7600686</ArticleId>
<ArticleId IdType="pmc">PMC1142614</ArticleId>
</ArticleIdList>
<ReferenceList>
<Reference>
<Citation>EMBO J. 2001 May 1;20(9):2152-9</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">11331581</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Anal Biochem. 1994 Apr;218(1):1-13</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">8053542</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Mol Hum Reprod. 2001 Aug;7(8):697-704</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">11470856</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Mol Med (Berl). 2001 Jun;79(5-6):226-42</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">11485015</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Cell. 2001 Aug 10;106(3):381-90</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">11509186</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Mol Endocrinol. 2002 Apr;16(4):736-46</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">11923470</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Pharmacol Rev. 2002 Jun;54(2):323-74</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">12037145</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Mol Endocrinol. 2002 Jun;16(6):1299-308</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">12040016</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Nat Rev Drug Discov. 2002 Oct;1(10):769-83</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">12360255</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Trends Pharmacol Sci. 2002 Aug;23(8):351-4</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">12377570</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Biol Chem. 2002 Nov 22;277(47):45059-67</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">12223484</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Biol Chem. 2002 Nov 22;277(47):44925-31</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">12244098</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Nature. 2003 Jan 9;421(6919):127-8</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">12520290</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Biol Chem. 2003 Feb 14;278(7):4385-8</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">12496294</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>EMBO J. 2003 Jun 2;22(11):2692-703</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">12773385</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Pharmacol Ther. 2003 Jun;98(3):325-54</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">12782243</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Biol Chem. 2003 Jun 13;278(24):21655-62</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">12663652</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Curr Opin Pharmacol. 2003 Oct;3(5):551-6</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">14559102</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Nature. 2003 Nov 6;426(6962):30-1; discussion 31</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">14603306</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>EMBO Rep. 2004 Jan;5(1):30-4</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">14710183</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Biol Chem. 2004 Feb 13;279(7):5904-14</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">14594799</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Trends Biochem Sci. 2004 Mar;29(3):119-26</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15003269</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Mol Endocrinol. 2004 Apr;18(4):968-78</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">14726491</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Anal Biochem. 2004 Jun 15;329(2):253-62</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15158484</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Pharmacol Ther. 2004 Jul;103(1):21-80</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15251227</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Nat Struct Mol Biol. 2004 Aug;11(8):706-13</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15235591</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Biol Chem. 2004 Aug 20;279(34):35526-34</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15199056</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Trends Biochem Sci. 1995 Nov;20(11):448-55</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">8578587</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Endocrinology. 1996 Nov;137(11):4586-91</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">8895321</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Biochem Pharmacol. 1997 Mar 21;53(6):795-800</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">9113100</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Biol Chem. 1997 Oct 3;272(40):25006-12</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">9312107</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>FEBS Lett. 1998 Oct 9;436(3):427-33</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">9801163</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Endocr Rev. 1998 Dec;19(6):673-716</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">9861544</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Proc Natl Acad Sci U S A. 1999 Jan 5;96(1):151-6</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">9874787</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>EMBO J. 1999 Apr 1;18(7):1723-9</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">10202136</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Biol Chem. 2004 Nov 26;279(48):49664-70</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15358776</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Mol Endocrinol. 2004 Dec;18(12):3020-34</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15319453</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Biochemistry. 2004 Dec 21;43(50):15643-56</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15595821</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Mol Pharmacol. 2005 Feb;67(2):460-9</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15509716</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Nature. 2005 Jan 20;433(7023):269-77</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15662415</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Curr Opin Struct Biol. 1996 Dec;6(6):757-61</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">8994875</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Proc Natl Acad Sci U S A. 2000 Mar 28;97(7):3684-9</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">10725388</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Curr Biol. 2000 Mar 23;10(6):341-4</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">10744981</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Neuron. 2000 Jul;27(1):97-106</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">10939334</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Clin Endocrinol Metab. 2000 Nov;85(11):4347-53</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">11095478</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Mol Endocrinol. 2001 Apr;15(4):534-42</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">11266505</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Nat Rev Neurosci. 2001 Apr;2(4):274-86</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">11283750</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Mol Cell Endocrinol. 1974 Apr;1(2):139-55</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">4376093</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Proc Natl Acad Sci U S A. 1979 Feb;76(2):705-9</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">218217</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Ann Endocrinol (Paris). 1979;40(3):211-27</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">224798</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Cell. 1981 Dec;27(2 Pt 1):279-88</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">6277501</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Biochem Biophys Res Commun. 1988 Jan 29;150(2):694-701</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">3277631</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Mol Endocrinol. 1994 Apr;8(4):498-509</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">7914349</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Biol Chem. 2001 Jun 22;276(25):22991-9</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">11312274</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
</PubmedData>
</pubmed>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/MersV1/Data/PubMed/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 002337 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd -nk 002337 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    MersV1
   |flux=    PubMed
   |étape=   Corpus
   |type=    RBID
   |clé=     pubmed:15889138
   |texte=   Glycoprotein hormone receptors: link between receptor homodimerization and negative cooperativity.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/RBID.i   -Sk "pubmed:15889138" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd   \
       | NlmPubMed2Wicri -a MersV1 

Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Mon Apr 20 23:26:43 2020. Site generation: Sat Mar 27 09:06:09 2021